Twitxy Saved

Shikha Wadhwani

@SWadhwaniMD

Nephrologist focused on glomerular diseases | Associate Research Officer | Vice Chair for Clinical Research | Director of Neph Clinical Trials | @utmbhealth
Galveston, TX Joined February 2019
660 Following 1.6K Followers 972 Posts

Latest posts 5

Pinned post

Shikha Wadhwani @SWadhwaniMD
Today I witnessed the most selfless, inspiring, gift of life πŸ’ My colleague & dear friend Aleks just donated a kidney to a complete stranger. I had no idea what to take this incredible human! So I got a plush kidney to keep her remaining one company πŸ’œ
79 replies 100 reposts 1.7K likes 195K views View on X
Shikha Wadhwani @SWadhwaniMD
When you’re scheduled to give a talk on APRIL/BAFF & IgAN biomarkers 24 hours after a #KidneyWk plenary session with 3 IgAN late-breakers (!!!)….you are up all night making brand new slides πŸ™ˆ

Totally worth it when you walk in to see a packed room of colleagues (who stayed long after lunch to engage in discussions with us!!)

πŸ™πŸΌ@ASNKidney for having as part of a fantastic session!
1 replies 2 reposts 42 likes 3.2K views View on X
Shikha Wadhwani @SWadhwaniMD
HUGE news!! Thrilled to see 4 of my absolute favorite people (not just nephrologists!) in the 🌎 appointed to the ISGD board πŸ™Œ Each is a mega superstar in his/her own right so the combination of their expertise & global perspectives = 🀯 @BradRovin @kidneydoc101 @KretzlerM
International Society of Glomerular Disease Verified account @ISGDtweets Aug 21
🌎 ISGD welcomes 4 new Board leaders!

πŸ”¬ Kretzler β€” translational research
πŸ§ͺ Rovin β€” clinical trials
πŸ‘§ Vivarelli β€” pediatric nephrology
πŸ’œ Lightstone β€” lupus nephritis & patient advocacy
πŸ‘‰ Read more: is-gd.org/en/news-from-i…
View quoted post on X
2 replies 1 reposts 10 likes 2.2K views View on X
Shikha Wadhwani @SWadhwaniMD
Check out this episode of our podcast #KidneyCompass where Dr. @brendonneuen discusses the TURING trial latebreaker at the European Renal Association meeting with Dr. Wilcocks! So many of us have been using Rituximab for these patients but we never had a trial in adults supporting it. Now we do! #TeamLessSteroids!
Brendon Neuen @brendonneuen Aug 20
Reducing cumulative steroid exposure is a key goal in patients with steroid-dependent, frequently relapsing MCD & FSGS

At #ERA26, I spoke with Dr Lisa Wilcocks about the TURING trial evaluating rituximab in these patients

Full #KidneyCompass episode now live
View quoted post on X